Influence of methylprednisolone on the reversal time of sugammadex: a randomized clinical trial
Background and objectives: Sugammadex is a modified gamma-cyclodextrin that reverses the effects of aminosteroidal neuromuscular blocking agents. Likewise, some steroid molecules, such as toremifene, fusidic acid, and flucloxacillin, can also be encapsulated by sugammadex. Methylprednisolone, which...
Main Authors: | Merve Hayriye Kocaoğlu, Başak Ceyda Meço, Menekşe Özçelik, Yeşim Batislam |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | Brazilian Journal of Anesthesiology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0104001420300440 |
Similar Items
-
Sugammadex revierte el bloqueo inducido por rocuronio en cesáreas: serie de 7 casos clínicos
by: Paloma Poza Hernández
Published: (2012-05-01) -
Use of sugammadex on burn patients: descriptive study
by: Eduardo Rodríguez Sánchez M., et al.
Published: (2015-08-01) -
Functional respiratory imaging after neostigmine- or sugammadex-enhanced recovery from neuromuscular blockade in the anesthetised rat: a randomised controlled pilot study
by: Tom Schepens, et al. -
The effect of gender on reversal of non-depolarizing block with Sugammadex
by: Alper Ozturk, et al.
Published: (2018-06-01) -
Cuando el reloj corre en tu contra, ¿rocuronio o succinilcolina?
by: Patricia Peralta Rodríguez, et al.
Published: (2017-04-01)